Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053)
Sarepta Announces Agreement with Nationwide Children’s Hospital for Rights to its Gene Therapy Program
pharmaceutical investing Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results
Prismo Metals Announces Closing of Upsized Private Placement Silver King Exploration to Begin in July
